Index terms: Liver; Hepatocellular; Carcinoma; Diffusion
Dear Sir, We are pleased to read the interesting article by Injoong Kim and colleagues (1) in the October 2012 issue of Korean Journal of Radiology. The authors examined the the histologic characteristics of hepatocellular carcinomas (HCCs) showing atypical enhancement patterns which would definitely add to the current literature. They found that HCCs showing atypical dynamic enhancement are usually smaller than typical HCCs. Since we have special interest on the diffusion magnetic resonance imaging (MRI) subject (2), we want to contribute information about the radiological evaluation of the small HCC nodules. HCC is the most common primary liver cancer and generally develops secondarily to chronic hepatitis or cirrhosis in elderly individuals. In the differential diagnosis of hepatocellular nodules up to 1 cm in diameter in the cirrhotic liver, regenerative nodules, low or high grade dysplastic nodules and early or progressed HCC should be considered. This poses a difficulty for the radiologist, especially in differentiation of dysplasia or HCC.
Diffusion weighted imaging (DWI) is virtually useless in detecting and characterizing borderline lesions in cirrhosis but ADC measurement of DWI may estimate the tumor grade of these HCCs since ADC tends to decrease in the order of well, moderately and poorly differentiated HCCs (3). Second, it was reported that if the liver function is normal, T2 weighted images may have the highest sensitivity among the other imaging parameters for differentiating HCCs 1 cm or smaller from benign hypervasculer lesions (4) . Also, in this study (4) it was found that the combination of T2 sequence and DWI have high specificity in detection of HCC which is important -especially in elderly patients -against the risk of using contrast material. Third, due to the different histopathological features of liver parenchyme or HCC, DWI is useful in determining hepatic metastases commonly seen in elderly people and in atypical hemangioma cases which are defined by hypervasculer enhancement on the arterial phase (3). Lastly, after invasive treatments (transcatheter arterial chemoembolization, thermal ablation, partial hepatectomy and irradiation) of HCCs 1 cm or smaller, DWI helps to detect hypervascular intrahepatic HCC metastases or regional HCC recurrence by excluding the interference of early enhancing pseudolesions due to the postoperative arterioportal shunting (3).
